169 related articles for article (PubMed ID: 34680167)
1. CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration.
Morales X; Peláez R; Garasa S; Ortiz de Solórzano C; Rouzaut A
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680167
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.
Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P
J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087
[TBL] [Abstract][Full Text] [Related]
3. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
[TBL] [Abstract][Full Text] [Related]
4. Druggability of CRMP2 for Neurodegenerative Diseases.
Khanna R; Moutal A; Perez-Miller S; Chefdeville A; Boinon L; Patek M
ACS Chem Neurosci; 2020 Sep; 11(17):2492-2505. PubMed ID: 32693579
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.
Oliemuller E; Peláez R; Garasa S; Pajares MJ; Agorreta J; Pío R; Montuenga LM; Teijeira A; Llanos S; Rouzaut A
Int J Cancer; 2013 May; 132(9):1986-95. PubMed ID: 23023514
[TBL] [Abstract][Full Text] [Related]
9. Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2.
Varrin-Doyer M; Nicolle A; Marignier R; Cavagna S; Benetollo C; Wattel E; Giraudon P
J Immunol; 2012 Feb; 188(3):1222-33. PubMed ID: 22227566
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization.
Yamashita N; Ohshima T; Nakamura F; Kolattukudy P; Honnorat J; Mikoshiba K; Goshima Y
J Neurosci; 2012 Jan; 32(4):1360-5. PubMed ID: 22279220
[TBL] [Abstract][Full Text] [Related]
12. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N
Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Adipogenesis and Lipid Deposits by Collapsin Response Mediator Protein 2.
Chang YH; Tsai JN; Chang SW; Hsu WT; Yang CP; Hsiao CW; Shiau MY
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245267
[TBL] [Abstract][Full Text] [Related]
14. PKCγ-Mediated Phosphorylation of CRMP2 Regulates Dendritic Outgrowth in Cerebellar Purkinje Cells.
Winkler SC; Shimobayashi E; Kapfhammer JP
Mol Neurobiol; 2020 Dec; 57(12):5150-5166. PubMed ID: 32860158
[TBL] [Abstract][Full Text] [Related]
15. Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications.
Li S; Zhang J; Zhang J; Li J; Cheng L; Chen L; Cha C; Guo G
CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):249-265. PubMed ID: 33109053
[TBL] [Abstract][Full Text] [Related]
16. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
17. Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Zheng Y; Sethi R; Mangala LS; Taylor C; Goldsmith J; Wang M; Masuda K; Carrami EM; Mannion D; Miranda F; Herrero-Gonzalez S; Hellner K; Chen F; Alsaadi A; Albukhari A; Fotso DC; Yau C; Jiang D; Pradeep S; Rodriguez-Aguayo C; Lopez-Berestein G; Knapp S; Gray NS; Campo L; Myers KA; Dhar S; Ferguson D; Bast RC; Sood AK; von Delft F; Ahmed AA
Nat Commun; 2018 Feb; 9(1):476. PubMed ID: 29396402
[TBL] [Abstract][Full Text] [Related]
18. Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.
Kinoshita Y; Kondo S; Takahashi K; Nagai J; Wakatsuki S; Araki T; Goshima Y; Ohshima T
Biochem Biophys Res Commun; 2019 Jul; 514(4):1037-1039. PubMed ID: 31097218
[TBL] [Abstract][Full Text] [Related]
19. Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.
Rahajeng J; Giridharan SS; Naslavsky N; Caplan S
J Biol Chem; 2010 Oct; 285(42):31918-22. PubMed ID: 20801876
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for CRMP2-induced axonal microtubule formation.
Niwa S; Nakamura F; Tomabechi Y; Aoki M; Shigematsu H; Matsumoto T; Yamagata A; Fukai S; Hirokawa N; Goshima Y; Shirouzu M; Nitta R
Sci Rep; 2017 Sep; 7(1):10681. PubMed ID: 28878401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
